Home › Funds › ADAR1 Capital Management, LLC › CLYM

ADAR1 Capital Management, LLC position in CLYM

CLIMB BIO INC · Health Care

ADAR1 Capital Management, LLC reported holding 822,649 shares of CLYM (CLIMB BIO INC) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 0.59% of its reported portfolio and ranking #45 among its reported holdings. ADAR1 Capital Management, LLC has disclosed CLYM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)822.65K sh
Reported value held$10.73M
Portfolio Weight0.59%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's CLYM position evolved

ADAR1 Capital Management, LLC first disclosed a stake in CLYM in Q2 2024 at 97,695 shares (US$695K). The position peaked in Q2 2026 at 822,649 shares, worth US$10.7M. Across 9 filings, ADAR1 Capital Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 822,649 shares valued at US$10.7M — an increase of 224,987 shares quarter over quarter.. Notable position changes include a 71% trim in Q4 2024 (shares fell 32% over the following quarter), a 148% increase in Q1 2025 (shares rose 2% over the following quarter), a 973% increase in Q4 2025 (shares rose 71% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 97.69K $694.61K New
Q3 2024 163.44K $831.92K Add
Q4 2024 48.12K $86.62K Reduce
Q1 2025 119.32K $145.57K Add
Q2 2025 119.32K $147.96K Hold
Q3 2025 133.53K $268.39K Add
Q4 2025 1.43M $5.73M Add
Q1 2026 597.66K $4.09M Reduce
Q2 2026 822.65K $10.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLYM and 13F data

CLYM (CLIMB BIO INC) is a Health Care company. 75 other funds we track also report a position in CLYM — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$147.4M), BRAIDWELL LP (US$36.5M), Cormorant Asset Management, LP (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLYM

All CLYM fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held CLYM?

ADAR1 Capital Management, LLC has disclosed CLYM holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is ADAR1 Capital Management, LLC's current position in CLYM?

As of Q2 2026, ADAR1 Capital Management, LLC holds 822.65K shares of CLYM (CLIMB BIO INC), valued at $10.73M, representing 0.59% of its reported portfolio and ranking #45.

Has ADAR1 Capital Management, LLC been buying or selling CLYM?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in CLYM. The position peaked in Q2 2026 at 822.65K shares.

Which other funds hold CLYM?

Other major institutional holders of CLYM include RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Cormorant Asset Management, LP, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.